Back
Stoke Therapeutics, Inc. Stock Predictions
AI Powerhouse Raises Price - But Room Remains
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Buy
66
STOK
Stoke Therapeutics, Inc.
Last Price:
$31.06
Seasonality Move:
14.31%
7 Day Trial
ALL ACCESS PASS
$
7
This AI Layer Just Raised Its Share Price
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiStoke Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Stoke Therapeutics, Inc. has on average historically risen by 47.4% based on the past 6 years of stock performance.
-
Stoke Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
-
Is Stoke Therapeutics, Inc. Stock Undervalued?The current Stoke Therapeutics, Inc. [STOK] share price is $31.05. The Score for STOK is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
STOK is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
Will Stoke Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Stoke Therapeutics, Inc. has on average historically risen by 47.4% based on the past 6 years of stock performance.
Stoke Therapeutics, Inc. Stock Rating
Buy
66
Stoke Therapeutics, Inc. (STOK)
is a Buy
Is Stoke Therapeutics, Inc. overpriced?
-
Stoke Therapeutics, Inc. has risen higher in 3 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 50%
Stoke Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
stoketherapeutics.com
52-Week Data
52-Week High:
38.69
52-Week Low:
5.35
Prediction Charts
Market Cap:
1.8B
Price in USD:
31.05
Volume:
660.4K
Beta:
0.95
Technical Analysis
SMA50:
28.74
SMA100:
23.20
SMA200:
16.26
52-Wk Change:
142.39%
Stock Predictions
-
Is Stoke Therapeutics, Inc. stock public?Yes, Stoke Therapeutics, Inc. is a publicly traded company.
-
What is the Stoke Therapeutics, Inc. stock quote today?The Stoke Therapeutics, Inc. stock price is 31.05 USD today.
-
How to buy Stoke Therapeutics, Inc. stock online?You can buy Stoke Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Nov-14 | 25.89 | 26.51 | 27.93 | 25.38 |
| Nov-17 | 26.42 | 26.95 | 27.63 | 25.31 |
| Nov-18 | 27.00 | 28.92 | 29.44 | 26.47 |
| Nov-19 | 28.92 | 28.48 | 29.14 | 27.56 |
| Nov-20 | 28.98 | 27.93 | 29.38 | 27.76 |
| Nov-21 | 27.82 | 29.34 | 29.46 | 27.53 |
| Nov-24 | 29.42 | 30.34 | 30.69 | 29.13 |
| Nov-25 | 30.57 | 29.82 | 30.94 | 28.51 |
| Nov-26 | 29.95 | 31.21 | 31.38 | 29.37 |
| Nov-28 | 31.22 | 30.91 | 31.44 | 30.28 |
| Dec-1 | 30.73 | 30.09 | 30.73 | 29.32 |
| Dec-2 | 29.80 | 29.81 | 30.71 | 28.74 |
| Dec-3 | 29.81 | 30.96 | 31.23 | 29.70 |
| Dec-4 | 30.23 | 31.05 | 31.54 | 30.10 |
Stoke Therapeutics, Inc. Earnings
Stoke Therapeutics, Inc. Earnings Report: Per Share Stoke Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Stoke Therapeutics, Inc. Forecast Revenue Growth
Stoke Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Stoke Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.23 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.07 per share, and a decrease next year of $3.13 per share.
* Stoke Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.